Morphological changes following experimental intraventricular haemorrhage and intraventricular fibrinolytic treatment with recombinant tissue plasminogen activator

Acta Neuropathologica

Volumn 100, Issue 5, 2000, Pages 561-567

  Mayfrank, L ^a   Kim, Y ^a   Kissler, J ^a   Delsing, P ^a   Gilsbach, J M ^a   Schroder J M ^a   Weis, J ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Cerebral haemorrhage; Ependyma; Intraventricular haemorrhage; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; SODIUM CHLORIDE; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; BLOOD CLOT LYSIS; BLOOD CLOTTING; BRAIN VENTRICLE; BRAIN VENTRICLE DILATATION; BRAIN VENTRICLE HEMORRHAGE; CONTROLLED STUDY; EPENDYMA CELL; EXPERIMENTAL MODEL; FIBRINOLYSIS; HYDROCEPHALUS; MALE; MORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALS; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; CEREBROVASCULAR CIRCULATION; FIBRINOLYTIC AGENTS; INJECTIONS, INTRAVENTRICULAR; INTRACRANIAL PRESSURE; MALE; RECOMBINANT PROTEINS; SWINE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033812915     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010000219     Document Type: Article

References (48)

1. Treatment of intraventricular hemorrhage by intraventricular infusion of urokinase
2. Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality
3. Ependymal development, proliferation, and functions: A review
4. A cohort study of the safety and feasibility of intraventricular urokinase for nonaneurysmal spontaneous intraventricular hemorrhage
5. Primary intraventricular hemorrhage: Clinical and neuropsychological finding in a prospective stroke series
6. Death and functional outcome after spontaneous intracerebral hemorrhage. A prospective study of 166 cases using multivariate analysis
7. Neuropathological changes caused by hydrocephalus
8. The ependyma: A protective barrier between brain and cerebrospinal fluid
9. Changes of periventricular vasculature of rabbit brain following induction of hydrocephalus and after shunting
10. Intraventricular haemorrhage caused by aneurysms and angiomas
11. Plasminogen activators potentiate thrombin-induced brain injury
12. Clinical aspects of intraventricular haemorrhage
13. Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm
14. Treatment of intraventricular hemorrhage with tissue plasminogen activator
15. Prognostic factors in patients with intracerebral haematoma
16. Primary intraventricular hemorrhage in adults
17. Computed tomographic diagnosis of intraventricular hemorrhage. Etiology and prognosis
18. Management of intraventricular haemorrhage in patients with haemorrhagic cerebrovascular diseases
19. Functional outcome after aneurysmal subarachnoid haemorrhage
20. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1. Overall management results
21. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro
22. The incidence of surgical complications is similar in good and poor grade patients undergoing repair of ruptured anterior circulation aneurysms: A retrospective review of 355 patients
23. Morphological changes of the basilar artery, ventricles, and choroid plexus after experimental hydrocephalus
24. Immediate prognosis of primary intracerebral hemorrhage using an easy model for the prediction of survival
25. Effect of recombinant tissue plasminogen activator on clot lysis and ventricular dilatation in the treatment of severe intraventricular hemorrhage
26. The effects of tissue-type plasminogen activator (tPA) on clot lysis and ventricular dilation in a new experimental model of intraventricular haemorrhage
27. Ventricular dilatation in experimental intraventricular hemorrhage. Characterization of CSF dynamics and the effects of fibrinolytic treatment
28. Fibrinolytic treatment of intraventricular haemorrhage preceding surgical repair of ruptured aneurysms and arteriovenous malformations
29. Intraventricular hemorrhage from ruptured aneurysms
30. Lysis of intraventricular blood clot with urokinase in a canine model. Part 1. Canine intraventricular blood cast model
31. Lysis of intraventricular blood clot with urokinase in a canine model. Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus
32. The surgical treatment of intracerebral and intraventricular haematomas
33. Intracerebral haemorrhage: A model for the prediction of outcome
34. Urokinase infusion for severe intraventricular haemorrhage
35. Intraventricular recombinant tissue plasminogen activator for lysis of intraventricular haemorrhage
36. Pathophysiology of periventricular tissue changes with raised CSF pressure in cats
37. Ependymal reactions to injury
38. Fibrinolysis of intraventricular haematoma with rt-PA
39. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage
40. Hemorrhagic dilation of the fourth ventricle: An ominous predictor
41. Treatment of intraventricular hemorrhage using urokinase
42. Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase
43. Clinical implications of the involvement of tPA in neuronal cell death
44. Excitotoxin-induced neuronal degeneration and seizure mediated by tissue plasminogen activator
45. Intracerebral hemorrhage: External validation and extension of a model for prediction of 30-day survival
46. A study on the efficacy of intraventricular urokinase in the treatment of intraventricular haemorrhage
47. Prognostic significance of ventricular blood in supratentorial hemorrhage: A volumetric study
48. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wilde-type and tPA-deficient mice